×
About 38,665 results

ALLMedicine™ Glaucoma Center

Research & Reviews  12,429 results

Selective laser trabeculoplasty is safe and effective in patients previously treated wi...
https://doi.org/10.1007/s10792-022-02460-w
International Ophthalmology; Ruiz-Lozano RE, Alamillo-Velazquez J et. al.

Aug 13th, 2022 - Prostaglandin analogs (PGAs) are first-line treatments for ocular hypertension (OHT) and open-angle glaucoma (OAG). However, frequent side effects and high costs hinder patient's compliance resulting in disease progression. Evidence suggests selec...

Glaucoma drainage implant exposure: A review of aetiology, risks and repair considerati...
https://doi.org/10.1111/ceo.14144
Clinical & Experimental Ophthalmology; Lun KW, Chew PTK et. al.

Aug 13th, 2022 - In recent years, there has been a paradigm shift in glaucoma surgical procedures. Glaucoma drainage implant (GDI) surgeries are being performed much more commonly. Thus, it is important for surgeons to be cognisant of potential complications and t...

Ambient Air Pollution and Age-Related Eye Disease: A Systematic Review and Meta-Analysis.
https://doi.org/10.1167/iovs.63.9.17
Investigative Ophthalmology & Visual Science; Grant A, Leung G et. al.

Aug 13th, 2022 - To compare the burden of age-related eye diseases among adults exposed to higher versus lower levels of ambient air pollutants. MEDLINE, EMBASE, and Scopus were searched for relevant articles until September 30, 2021. Inclusion criteria included s...

Macular Layer Thickness and Effect of BMI, Body Fat, and Traditional Cardiovascular Ris...
https://doi.org/10.1167/iovs.63.9.16
Investigative Ophthalmology & Visual Science; von Hanno T, Hareide LL et. al.

Aug 13th, 2022 - The purpose of this study was to investigate associations between cardiovascular risk factors and the thickness of retinal nerve fiber layer (RNFL), ganglion cell-inner plexiform layer (GCIPL), and outer retina layers (ORL). In this population-bas...

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
https://clinicaltrials.gov/ct2/show/NCT04499248

Aug 12th, 2022 - This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-group (Cohort 2) study to evaluate the safety and efficacy of AGN-193408 SR in participants with open-angle glaucoma or ocular hypertension

see more →

Guidelines  12 results

Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®.
https://doi.org/10.1016/j.ophtha.2020.10.023
Ophthalmology Gedde SJ, Lind JT et. al.

Dec 23rd, 2021 - Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®.|2021|Gedde SJ,Lind JT,Wright MM,Chen PP,Muir KW,|standards,standards,diagnosis,physiopathology,therapy,physiology,diagnosis,physiopathology,therapy,organization & administration,stan...

Primary Open-Angle Glaucoma Preferred Practice Pattern®.
https://doi.org/10.1016/j.ophtha.2020.10.022
Ophthalmology Gedde SJ, Vinod K et. al.

Dec 23rd, 2021 - Primary Open-Angle Glaucoma Preferred Practice Pattern®.|2021|Gedde SJ,Vinod K,Wright MM,Muir KW,Lind JT,|standards,standards,diagnosis,physiopathology,therapy,physiology,pathology,organization & administration,standards,pathology,

The Health Exam You Didn’t Know You Needed
https://www.aao.org/newsroom/news-releases/detail/health-exam-you-didnt-know-you-needed
American Academy of Ophthalmology

May 12th, 2021 - SAN FRANCISCO, Calif. – If you’re like most Americans surveyed in a recent Harris Poll, you probably thought you would notice a change in your vision if you had an eye disease. The fact is some of the leading causes of blindness—such as glaucoma o...

Staying away from the optic nerve: a formula for modifying glaucoma drainage device sur...
https://doi.org/10.1016/j.jaapos.2016.09.027
Journal of AAPOS : the Official Publication of the Americ... Margeta MA, Kuo AN et. al.

Jan 21st, 2017 - To provide guidelines for safe implantation of glaucoma drainage devices (GDDs) in small and pediatric eyes to avoid contact between the optic nerve (ON) and the posterior edge of the GDD plate. We developed a formula for calculating limbus-to-ON ...

Screening for Impaired Visual Acuity in Older Adults: Clinical Summary
https://allmedx.com/USPSTFPDF/viselderscrsumm.pdf

Feb 23rd, 2016 - Screening for Impaired Visual Acuity in Older Adults: Clinical Summary Population Adults 65 years or older who do not present with vision problems Recommendation No recommendation. Grade: I (insufficient evidence) Risk Assessment Older a...

see more →

Drugs  422 results see all →

Clinicaltrials.gov  1,785 results

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
https://clinicaltrials.gov/ct2/show/NCT04499248

Aug 12th, 2022 - This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-group (Cohort 2) study to evaluate the safety and efficacy of AGN-193408 SR in participants with open-angle glaucoma or ocular hypertension

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
https://clinicaltrials.gov/ct2/show/NCT05401357

Aug 10th, 2022 - Subjects with chronic open-angle glaucoma or ocular hypertension in both the eyes and meeting all the mentioned inclusion criteria and none of the exclusion criteria will be identified. At baseline (Day 0), subjects qualifying Intra Ocular Pressur...

Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)
https://clinicaltrials.gov/ct2/show/NCT05495269

Aug 10th, 2022 - Open-label study of an investigational product (IP), QLS-101, with 28-day every morning (QAM) dosing to both eyes (OU) in adolescents with SWS who have clinical evidence of glaucoma and/or ocular hypertension (OHT) related to SWS elevated EVP in a...

A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
https://clinicaltrials.gov/ct2/show/NCT05495061

Aug 10th, 2022 - To investigate whether the IOP lowering efficacy of STN1012600 ophthalmic solution 0.002% is non-inferior to that of latanoprost 0.005% in subjects with POAG or OHT after treatment for 4 weeks.

STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program
https://clinicaltrials.gov/ct2/show/NCT02825264

Aug 9th, 2022 - This Clinical Experience Program is being initiated to expand the surgical and clinical practice knowledge about the use of STARflo for reducing intraocular pression (IOP) in patients suffering from open angle glaucoma in a real world population o...

see more →

News  794 results

Black People More Likely to Lose Eyesight From Glaucoma
https://www.medscape.com/viewarticle/977917

Jul 25th, 2022 - Black people are six times more likely than non-Hispanic white people to lose significant eyesight from glaucoma, even when they have similar access to healthcare, researchers say. Glaucoma also starts earlier on average in the lives of Black peop...

Blood Pressure, Blood Pressure Medications, and Glaucoma: A Conversation With Dr Ruth Williams
https://www.medscape.com/viewarticle/976943

Jul 18th, 2022 - Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about the association between blood pressure, blood p...

Myopia: A Silent and Growing Epidemic
https://www.medscape.com/viewarticle/977201

Jul 14th, 2022 - FRANCE — Today, close to 40% of adults in France are nearsighted. Experts say that in 2050, that number could be as high as 60%. The Institute for Medical Education and Prevention (IEMP) has launched a nationwide campaign to raise awareness about ...

Uveitis in juvenile arthritis patients persists into midlife
https://www.mdedge.com/rheumatology/article/256232/pediatrics/uveitis-juvenile-arthritis-patients-persists-midlife
Heidi Splete

Jul 13th, 2022 - Active uveitis remained in 43. 4% of juvenile idiopathic arthritis (JIA) patients up to 40 years after a diagnosis, based on data from 30 individuals.

Topical Eye Meds a Common Cause of Allergic Contact Dermatitis
https://www.medscape.com/viewarticle/976693

Jul 7th, 2022 - Various ingredients in topical eye medications may be causing allergic contact dermatitis at higher rates than assumed, a small retrospective cohort study suggests. "Allergic contact dermatitis caused by topical ophthalmic medications (OftACD) is ...

see more →

Patient Education  24 results see all →